002550 千红制药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.02615.09114.3207.41514.130
总资产报酬率 ROA (%)2.69213.47612.7236.52812.171
投入资产回报率 ROIC (%)3.01014.95114.0287.13813.454

边际利润分析
销售毛利率 (%)61.08058.35654.85243.26538.591
营业利润率 (%)28.68928.99825.97211.26415.628
息税前利润/营业总收入 (%)30.94828.95725.13710.86612.422
净利润/营业总收入 (%)23.59823.75521.8309.84813.888

收益指标分析
经营活动净收益/利润总额(%)90.42569.09774.14472.82986.680
价值变动净收益/利润总额(%)3.9234.0303.5094.312-1.273
营业外收支净额/利润总额(%)0.067-1.210-0.139-0.4090.090

偿债能力分析
流动比率 (X)7.2968.4687.5827.9006.065
速动比率 (X)5.8436.8175.6714.9754.136
资产负债率 (%)11.75210.42511.08910.56313.276
带息债务/全部投入资本 (%)-3.059-2.908-2.225-0.6541.024
股东权益/带息债务 (%)-3,253.565-3,419.328-4,435.120-14,863.1289,308.957
股东权益/负债合计 (%)751.492859.719802.064840.232657.760
利息保障倍数 (X)13.82094.604-31.468-30.840-3.857

营运能力分析
应收账款周转天数 (天)59.46258.62156.54178.39075.078
存货周转天数 (天)250.700219.862268.752199.089119.244